UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
Report for the Calendar Year or Quarter Ended:
12-31-2023
Check here if Amendment: ☒ Amendment Number:
1
This Amendment (Check only one.):☒ is a restatement.
☐ adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:
BML Capital Management, LLC
Address:
65 E CEDAR - SUITE 2
ZIONSVILLE, IN 46077
Form 13F File Number:
028-22948

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.


Person Signing this Report on Behalf of Reporting Manager:
Name:
Aryn Sands
Title:
Agent
Phone:
844-844-3453


Signature, Place, and Date of Signing:

Aryn Sands
                         [Signature]
Reno, NEVADA
                 [City, State]
02-01-2024
                           [Date]
                          

Report Type (Check only one.):

☒ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 

☐ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 

☐ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
0
Form 13F Information table Entry Total:
35
Form 13F Information table Value Total:
132023880
          (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

  
NONE


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ARCA BIOPHARMA INCCOM00211Y5061,201,781706,930SHSOLE 0 0 706,930
ABERCROMBIE & FITCH COCL A0028962073,033,000900SHPutSOLE 0 0 900
ACLARIS THERAPEUTICS INCCOM00461U105685,762653,107SHSOLE 0 0 653,107
ADVERUM BIOTECHNOLOGIES INCCOM00773U1083,428,4414,554,252SHSOLE 0 0 4,554,252
ASTROTECH CORPCOM0464843091,871,281220,410SHSOLE 0 0 220,410
ATEA PHARMACEUTICALS INCCOM04683R10616,659,3415,462,079SHSOLE 0 0 5,462,079
ATHIRA PHARMA INCCOM04746L1043,534,1001,454,362SHSOLE 0 0 1,454,362
AVROBIO INCCOM05455M1005,442,2134,001,627SHSOLE 0 0 4,001,627
BUILD-A-BEAR WORKSHOP INCCOM120076104465,0001,500SHPutSOLE 0 0 1,500
LISATA THERAPEUTICS INCCOM128058302736,660269,839SHSOLE 0 0 269,839
CONNECT BIOPHARMA HLDGS LTDADS2075231012,432,4972,061,438SHSOLE 0 0 2,061,438
CYTEIR THERAPEUTICS INCCOM23284P1039,880,0243,250,008SHSOLE 0 0 3,250,008
DESIGN THERAPEUTICS INCCOM25056L1032,728,1171,029,478SHSOLE 0 0 1,029,478
ELIEM THERAPEUTICS INCCOM28658R1065,886,0002,180,000SHSOLE 0 0 2,180,000
ENLIVEN THERAPEUTICS INCCOM29337E102692,00050,000SHSOLE 0 0 50,000
FORTE BIOSCIENCES INCCOM34962G1091,447,5911,761,702SHSOLE 0 0 1,761,702
GRAPHITE BIO INCCOM38870X1041,172,230447,416SHSOLE 0 0 447,416
CALCIMEDICA INCCOM NEW38942Q202415,913145,424SHSOLE 0 0 145,424
HOMOLOGY MEDICINES INCCOM438083107454,850748,108SHSOLE 0 0 748,108
INVESCO QQQ TRUNIT SER 146090E103661,200300SHPutSOLE 0 0 300
ISHARES TR0-3 MNTH TREASRY46436E71827,072,900270,000SHSOLE 0 0 270,000
KINNATE BIOPHARMA INCCOM49705R1051,109,658468,210SHSOLE 0 0 468,210
MILESTONE PHARMACEUTICALS INCOM59935V107738,728442,352SHSOLE 0 0 442,352
NEUROGENE INCCOM64135M105478,02724,666SHSOLE 0 0 24,666
NEXTCURE INCCOM65343E108349,370306,465SHSOLE 0 0 306,465
ORAMED PHARMACEUTICALS INCCOM NEW68403P2032,914,2011,261,559SHSOLE 0 0 1,261,559
RAIN ONCOLOGY INCCOM75082Q1051,618,8081,349,007SHSOLE 0 0 1,349,007
RENEO PHARMACEUTICALS INCCOM75974E1032,102,7661,314,229SHSOLE 0 0 1,314,229
SPDR SER TRBLOOMBERG 1-3 MO78468R66318,278,000200,000SHSOLE 0 0 200,000
TALIS BIOMEDICAL CORPCOM NEW87424L207318,43542,743SHSOLE 0 0 42,743
THESEUS PHARMACEUTICALS INCCOM88369M1014,488,6961,108,320SHSOLE 0 0 1,108,320
TOURMALINE BIO INCCOM89157D1056,427,190245,500SHSOLE 0 0 245,500
VERRICA PHARMACEUTICALS INCCOM92511W1081,317,600180,000SHSOLE 0 0 180,000
VISTAGEN THERAPEUTICS INCCOM92840H400771,000150,000SHSOLE 0 0 150,000
WINGSTOP INCCOM9741551031,210,500900SHPutSOLE 0 0 900